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Considerable attention has been given by workers in the field of experi- 
mental poliomyelitis to the ability of poliomyelitis virus to infect monkeys 
by  different routes  of injection.  The  results  of such  experimental  work 
have  led  to  numerous  theories  with  respect  to  the  transmission  of  the 
disease  in  man,  the  nature  and  character  of  different  strains,  and  the 
possibility  of  producing  immunity  by  prophylactic  administration  of 
virus.  The  purpose  of the  work here  reported  was  to  test  the  suscepti- 
bility of monkeys to the intracutaneous route of inoculation and to deter- 
mine  the  immunity  produced  in  the  animals  remaining  symptomless 
following such injections, with strains of virus which previously had been 
found  to  vary  considerably  in  virulence  and  immunologic  reaction  as 
determined by neutralization tests. 
It has been observed in the course of immunization  experiments using active virus 
injected into  the  skin,  that,  on  occasion,  monkeys developed  typical symptoms of 
poliomyelitis.  In one series of 20 monkeys, Aycock and Kagan (1), 1927, found one 
animal developing paralysis  during such  treatment.  Trask and Paul (2),  1936, con- 
sidered of particular significance the fact that one strain, Wfd, of comparatively low 
virulence  by the intracerebral  route  and not infective  intranasally, demonstrated a 
unique property of infecting four of five animals injected by the intracutaneous route. 
In a  later report,  the  same  workers  (3)  investigating  the intracutaneous infectivity 
of eleven strains reported that the "fresh" or recently isolated strain showed this property 
in a  third of a  small series of inoculated animals.  In another instance,  a  strain re- 
covered in Northern California was reported  by Howitt (4)  to have infected the two 
monkeys given small doses intradermaUy  in immunization attempts. 
Intracutaneous  Infectiv#y 
During a comparative  study of seven strains of poliomyelitis virus (5) attempts were 
made to determine the susceptibility  of monkeys by different routes of infection.  Five 
of these, McK, P, McS, BK, and ST were recovered at the Los Angeles County Hospital, 
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and all were in the third or fourth passage when used in these experiments.  The other 
two  were  the long established  MV strain  and  a  recent  strain,  the  BO,  which  was  re- 
covered by Dr. W. L. Aycock in Boston, 1936, and estimated to be in the sixth or seventh 
TABLE  I 
Susceptibility  of  Monkeys  to  Poliomyelitis  Virus  by  the  Intracutaneous  Route 
(2 cc. dose of 5 per cent suspension  of pooled cords from each strain given at each 
injection) 
Virus  1st  2nd  3rd 
Monkey  injection  injection  injection 
8-37,-38  10/30/36  11/  9/36  11/27/36 
10-64  1/27/37  2/11/37  3/16/37 
10-65  "  "  " 
10-66, -67  "  "  -- 
8-39,-40  10/30/36  11/  9/36  11/27/36 
10-68  1/27/37  2/11/37  -- 
10-69  ....  3/16/37 
10-70  "  "  ,, 
10-71  "  "  ,' 
4th 
inj.ction 
11/30/36 
6/22/37 
11/30/36 
6/22/37 
8-71  11/27/36  11/30/36  -- 
8-72  ,,  ,,  1 
8-73*  1/15/37  --  --  -- 
10-72  1/27/37  --  --  -- 
10-73  "  --  --  -- 
10-74  "  --  -- 
10-75  "  2/i1/37  --  -- 
10-76, -77,  -78  1/27/37  2/11/37  3/16/37  -- 
10-79, -80,  -81  ......  6/22/37 
8-41  10/30/36  I1/  9/36  -- 
8-42  ....  11/27/36  11/30/36 
13-35, 14-89,-90, -98  6/22/37  7/15/37~ 
15-00  to  15-06  6/22/37  7/15/37 
inclusive 
14-88, 15-05  6/22/37  7/15/37 
15-07  "  -- 
15-08  "  " 
15-09  "  -- 
15-10  "  " 
Results 
No symptoms 
No symptoms 
Paralysis 13 day 
No symptoms 
Paralysis  15 day 
Int. infection 
Paralysis 13 day 
Paralysis 12 day 
Int. infection 
I  No symptoms 
Paralysis 14 day 
No symptoms 
No symptoms 
No symptoms 
Int. infection 
No symptoms 
Paralysis 7 day 
No symptoms 
* This animal had three intranasal  injections 6  weeks previously without symptoms. 
passage.  Six  or  more  rhesus  monkeys  were  given  intradermal  injections  with  each 
strain  in  doses of 2  cc.  of a  5  per cent virus  suspension  administered  in  several blebs 
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able interest  in that three  animals developed paralysis  on the 12th to 15th day after a 
single injection  and one animal  on the 13th day after a second injection with the McS 
strain.  Two animals  died  during the experiment  from intercurrent infection  and one 
remained  symptomless.  The P  strain,  tested  at  the same  time,  infected  one  animal 
which developed paralysis  on the 14th day; and the BO, in tests  made later,  infected 
only one animal.  It is felt that these last two positive  cases are of minor significance 
since such occasional positive findings might occur with any strain.  All of the strains 
employed  in  the intradermal  tests  were infective  by the  intranasal  and intracerebral 
routes  with  an incubation  period  of 6 to 9 days, depending  upon the strain.  It is of 
TABLE  II 
Intracutaneous Passage Series with McS Strain 
(1.0 cc. doses of 10 per cent suspension) 
Series I 
Series II 
Ist  passage 
Nov. 27, 1936 
Virus,  McS pool 
Brain passage IV 
8-71, paralysis  16 day 
8-72, no symptoms 
2nd passage 
Jan. 5,1939 
Virus, 8-71 
17-81,  paralysis 12 day 
17-84, 21-08, -09, -10, no 
symptoms 
3rd passage 
Jan. 19, 1939 
Virus, 17-81 
20-13, -15, -18, no symp- 
toms 
20-19, paralysis 15 day 
20-22, -63, -65, -66, -71, 
-79, no symptoms 
Intracerebral Controls 
21-11, paralysis 12 day  20-24, paralysis 14 day 
20-70, died Tbc. 20 day 
4th passage 
Mar. 3, 1939 
Virus, 20-19 
21-74,  no symptoms 
21-76,  paralysis  14 day 
21-77,  no symptoms 
Ist passage  2nd passage  3rd passage  4th passage 
May 20, 1938  June 4, 1938  Jan. 17,1939  Mar. 3, 1939 
Virus, McS pool 34  Virus, 194}7  Virus, 21-17  Virus, 20-43 
20-23,  -28,  -34,  -36,  no 
symptoms 
20-43, paralysis 9 day 
20-80 to 20-83~inclusive, 
no symptoms 
20-87, paralysis 10 day 
21-16, no symptoms 
21-17, paralysis 11 day 
21-18, -19, -20, no symp- 
toms 
18-98  to  194)6  inclusive, 
no symptoms 
19-07,  paralysis  8 day 
Intracerebral Controls 
19-79, paralysis 8 day  21-21, paralysis 12 day  20-30, paralysis 8 day 
20-72, paralysis  6 day 
21-78,  -79,  paralysis  9 
day 
21-80, no symptoms 
especial  interest  to  note  that  monkey 8-73 had  received  three  intranasal  injections 
about 6 weeks previously  without the occurrence  of symptoms, but became  infected 
after one injection  into the skin. 
These  findings indicated  that  the  McS  strain  in particular  might be  of 
dermatophilic  nature,  so  attempts  were  made  to  establish  this  as  a  par- 
ticular  characteristic  and  to  determine  whether  this  characteristic  would 
be maintained in successive intradermal passages.  Two series of passages 
were carried out as shown in Table II. 
In series I, the first passage monkeys were injected  with pooled virus material from 
fourth brain passage animals,  whereas  the first  passage  monkeys  of series II  were in- 648  INFECTIVITY AND  IMMUNITY AFTER POLIOMYELITIS INJECTION 
jected with a pool of different passage cords collected some time later.  For the second, 
third, and fourth passages in each series, cord virus material for injection was prepared 
from a sacrificed animal of the preceeding passage, and this same material was used for 
intracerebral controls.  There was an intervening period of 2 years between the first 
and second  passages of series I  in which  the cord virus 8-71 was stored.  Intradermal 
tests on four monkeys, however, in the middle of this period (Feb. 8, 1938) were negative 
with this same cord virus.  An interval of 6 months occurred between the second and 
third passages of series II.  It is not apparent that these irregularities influenced  the 
experiments.  Only in  the  third and fourth passages of series  II did more than one 
animal develop symptoms, the percentage in  the  fourth  passage being much  higher 
because of the small number of animals injected.  All of the controls showed infectivity 
by the intracerebral route although the incubation period showed some vfiriations. 
The intracerebral passages of this strain had been carried through the eighth passage 
by this time, and a  cord suspension  was injected intradermaLly into four monkeys as 
shown in Table III.  One animal developed paralysis after an extremely long incubation 
period of 38 days. 
TABLE  Ill 
Intracutaneous Injections of Recent Passage Virus 
McS virus, 8th intracerebral  passage 
Monkey  Injected  Result 
17-71  1/25/38 
17-72  " 
17-73, -74  " 
Control Intracerebral Injections 
17-70  [  1/25/38  I  Paralysis 8 day 
No symptoms 
Paralysis 38 day 
No symptoms 
It appears from this small series at least that the ability of the strain to 
produce infection through  the skin was somewhat less than  that shown in 
the passage experiments where early passage virus was used. 
Immunity Experiments 
In view of the  inconsistency  of the  earlier  results,  experiments using  a 
larger series of animals with six of the same strains of virus (the MV omitted) 
were planned,  first, to check again the  skin infectivity using active pooled 
cord material of each strain, and second, to  determine the immunity of the 
animals not  infected. 
As shown in Table IV, ten monkeys were given a series of three intracutaneous in- 
jections of 1 cc. of a 5 per cent virus suspension  with each strain within a period of 9 
days.  Only one  animal so injected developed symptoms and this was with the McS 
strain.  The control animals given one intracerebral injection of the same virus suspen- 
sions developed symptoms in the usual incubation period.  8 weeks after the last injec- FRED  D.  STIMPERT  AND  JOHN  F.  KESSEL  649 
tion, blood was taken from the 59 symptomless monkeys for future neutralization tests, 
and within an 8 week period following this, two series of intranasal injections were given 
TABLE  IV 
Results of IntradermaUy Injected Monkeys with Subsequent Intranasal Injections 
(10 animals used with each strain, each dose  =  1 co. of 5 per cent virus) 
Virus 
McS 
P 
McK 
ST 
BK 
BO 
Intracutaneous 
injections 
May 17, 20,  26, 
1938 
1  paralyzed 
None 
4C 
C¢ 
Control 
intracerebral 
May 17, 1918 
Blood taken 
for  neu- 
traliza- 
tion tests, i 
July  25, 
1938 
1st series 
Aug. 4,5, 1938 
Intrsnasal injections 
Paralyzed 
cc 
c¢ 
cc 
None 
5 paralyzed 
3  . 
6 
2nd  series  Ira- 
Sept.  7, 9, 1938  mune 
per 
4 paralyzed  56 
None  100 
2 paralyzed  80 
2  "  30 
2  "  50 
None  40 
Controls 2 
monkeys each 
1 paralyzed 
2 
2 
1 
2 
TABLE  V 
Additional Intranasal Tests on Monkeys Remaining Syraptomless after 8 Months 
Virus 
McS 
P 
McK 
ST 
BK 
BO 
1 cc. of 5 per cent virus in each nostril 
May 15, 16, 17, 18, 19, 1939 
June 6, 7, 8, 9, 1939 
Test animals 
19-03, no symptoms 
19-06, Tbc. 7/6/39 
19-30, -31, -33, no symptoms 
18-92, -93, -94, no symptoms 
19-23, -26, no symptoms 
19-08, -12, -15, no  symptoms 
19-40, paralysis 5/25/39 
19-43, paralysis 6/22/39 
19-46, no symptoms 
Controls 
21-95, Tbc. 6/12/39 
22-13, no symptoms 
22-02, no symptoms 
224)4, Tbc. 5/24/39 
21-92, -93, no symptoms 
22-00, no symptoms 
22-01, paralysis 6/2/39 
21-97, -99, no symptoms 
22-05, Tbc. 5/24/39 
22-06, paralysis 6/19/39 
Iutracerebral control of virus 
June 6, 1939 
22-21, paralysis 6/13/39 
22-56, paralysis 6/12/39 
22-59, paralysis 6/14/39 
22-56, paralysis 6/12/39 
22-17, paralysis 6/16/39 
22-58, paralysis 6/14/39 
by administering 1 cc. of a 5 per cent virus suspension to each nostril, holding the animals 
in the head-down position so that the material reached the olfactory space. 
The  results  interpreted  in  Table  IV  show  a  variation  in  immunity  or 
resistance of animals to intranasal  injections from 30 to 100 per cent, after 650  INFECTIVITY  AND  IMMUNITY  AFTER  POLIOMYELITIS  INJECTION 
having received previous immunizing skin doses.  The control animals for 
the intranasal  administration,  however, were not positive in  100 per cent, 
the  McS,  ST,  and  BK  strains  infecting  only  one  of  the  two  animals  em- 
ployed  in  each  case. 
A  small number of these  resistant  animals,  including  the  negative  controls,  were 
still living 8 months later and were given two additional series of intranasal injections. 
In Table V, it will be noted that the BO strain infected two of the three animals and one 
of the controls, and the ST strain infected one of the controls.  Several died of tuber- 
TABLE  Vl 
Intrac~ebral  Tests on Monk.s Remaining Symptomless 
Virus 
McS 
P 
McK 
ST 
BK 
BO 
1 cc. of 5 per cent virus 
July 13, 1939 
Test animals 
19-03, paralysis 19 day 
19-30, no symptoms 
19-31, paralysis 8 day 
19-33, paralysis 7 day 
18-92, paralysis 10 day 
18-93, tremorous 9 day 
18-94, no symptoms 
19-23, paralysis 7 day 
19-26, paralysis 6 day 
19-08, no symptoms 
19-15, dead 6 day (?) 
19-46, paralysis 11 day 
Intranasal controls 
22-13, no symptoms 
22-02, paralysis 8 day 
21-92, paralysis 23 day 
21-93, no symptoms 
22-00, paralysis 8 day 
21-97, no symptoms 
21-99, no symptoms 
Intracerebral control of virus 
22-33, paralysis 8 day 
23-38, paralysis 7 day 
23-32, paralysis 8 day 
24-31, paralysis 6 day 
23-34, paralysis 7 day 
23-31, paralysis 8 day 
culosis during this time, but the remaining 20 animals were resistant.  To further check 
the resistance,  intracerebral injections were made, with seven animals in all remaining 
resistant, Table VI.  In the separate groups only one animal resisted the brain inocula- 
tion in the McS, P, and McK virus series,  none in the ST and BO, but all remained 
symptomless with the BK virus.  Monkey 19-15 of the BK series was found dead on 
the  6th  day without  any suspicious  symptoms of poliomyelitis, and  the  histological 
study of the brain and cord proved negative. 
DISCUSSION 
The  production  of  experimental  poliomyelitis  by  means  of  the  intra- 
cutaneous route of injection does not appear to be a  very common or con- 
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isolated ones demonstrated this ability.  This is in accord with the findings 
of Trask and Paul (3) in their investigations of "fresh" strains.  The McS 
strain which showed a  high degree of infectivity by this route when first 
tested failed to  act  in  the  same  degree when  tested with  later passage 
material.  No particular property could be attributed to this strain which 
might explain an affinity for infection through the skin.  Except for the 
high percentage of positive results in  the small group of animals in  the 
fourth passage  series  II,  Table  III,  neither did  the passing  of different 
stock  cord material of  virus  in  successive  intracutaneous series  nor  the 
preservation of the virus material used for injection appear to have any 
appreciable influence on the infectivity. 
Marked  differences in  the  degree  of  immunity occurred in  monkeys 
given intracutaneous doses of the six strains as determined by subsequent 
intranasal  and intracerebral injections.  The fact that  the monkeys im- 
munized with  the  P  and  McK  strains  developed the  highest degree of 
resistance against four series of intranasal injections is of some significance 
for these two strains vary considerably in virulence, the P  producing severe 
infection, and the McK mild; and were  found, in previous work  (5),  to 
show considerable variation  in  immunologic reactions as  determined by 
neutralization tests.  This, and the fact that the percentage of immunity 
in the BK group was only 50 per cent, whereas 100 per cent neutralization 
results were previously found, is  of additional interest  in that  it further 
supports  the  theory that  there  is  no  complete  correlation between the 
presence of neutralizing antibodies and  actual immunity to  injection of 
active virus. 
Although all  the strains were infective on numerous occasions  by  the 
intranasal route, the inability to infect all of the control animals by re- 
peated administration of active virus presents a  problem for further in- 
vestigation.  The respective virulence of  the  strain apparently is not the 
only factor, for in the  case of the McK, a mild strain, both the controls 
developed paralysis, while in the case of the ST, a severe strain, only one 
was positive--Table IV.  The still greater discrepancy in the controls of 
Table V might be explained on the basis  of variation in the resistance of 
monkeys, since these animals were from a different shipment.  The irregu- 
lar results obtained in general, however, by intranasal administration of 
virus would lead one to  assume that  a  number of unknown factors still 
exist.  Since  the  intranasal  method of  injection  would  theoretically be 
more ideal than the drastic intracerebral route for comparative experimen- 
tal  work,  further  experimentation would  be  necessary  with  a  greater 
number of strains before this method could be generally adopted. 652  INFECTIVITY  AND  IMMUNITY AFTER POLIOMYELITIS INJECTION 
SUMMARY 
The infectivity of poliomyelitis virus by the intracutaneous route occurs 
in certain strains  but is not a  constant character.  The inconsistency of 
skin infectivity tests  indicates  that  there is  some property yet unknown 
which influences this characteristic. 
Strains of poliomyelitis virus vary in the degree of immunity produced 
in experimental monkeys injected with active virus by the intracutaneous 
route and subsequently tested for resistance by intranasal injections.  The 
variation has no relation to  the virulence of the strain.  Further investiga- 
tion on the intranasal route of injection  should be carried on so that this 
method may be used with greater  assurance in  immunity tests,  and also 
in other procedures of poliomyelitis experimentation. 
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